speb/financial-data huggingface dataset:
DPM.AX balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 2409792000.00
DPM.AX income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -1242534.31
DPM.AX income_statement (quarterly, 2025-09-30) — Tax Provision: 12406000.00
DPM.AX income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.11
DPM.AX cash_flow (quarterly, 2025-09-30) — Taxes Refund Paid: -12223000.00
DPM.AX balance_sheet (quarterly, 2025-09-30) — Total Assets: 2936718000.00
DPM.AX balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 2423381000.00
DPM.AX balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 2423381000.00
DPM.AX income_statement (quarterly, 2025-09-30) — Total Expenses: 152531000.00
DPM.AX balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 513337000.00
DPM.AX balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 2242241000.00
DPM.AX balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 262953000.00
DPM.AX balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 9175000.00
DPM.AX income_statement (quarterly, 2025-09-30) — Total Unusual Items: -10856000.00
DPM.AX income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -10856000.00
DPM.AX balance_sheet (quarterly, 2025-09-30) — Working Capital: 444093000.00
DPM.AX income_statement (annual, 2025-12-31) — +Operating Expense: 175595000.00
DPM.AX income_statement (quarterly, 2025-12-31) — +Operating Expense: 59057000.00
DPM.AX income_statement (annual, 2025-12-31) — +Total Revenue: 950481000.00
DPM.AX income_statement (quarterly, 2025-12-31) — +Total Revenue: 352434000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Accounts Payable: 56881000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 56881000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Accounts Receivable: 225258000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 225258000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -818910000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -818910000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 6169000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 6169000.00
DPM.AX income_statement (annual, 2025-12-31) — Basic Average Shares: 185179142.00
DPM.AX income_statement (annual, 2025-12-31) — Basic EPS: 1.99
DPM.AX cash_flow (annual, 2025-12-31) — Beginning Cash Position: 634830000.00
DPM.AX cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 413611000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 95969000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 95969000.00
DPM.AX cash_flow (annual, 2025-12-31) — Capital Expenditure: -20082000.00
DPM.AX cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -5925000.00
DPM.AX cash_flow (annual, 2025-12-31) — Capital Expenditure Reported: -20082000.00
DPM.AX cash_flow (quarterly, 2025-12-31) — Capital Expenditure Reported: -5925000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 12422000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 12422000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Capital Stock: 1581126000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Capital Stock: 1581126000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 497797000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 497797000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 497797000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 497797000.00
DPM.AX cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -29416000.00
DPM.AX cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -8895000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Cash Equivalents: 160000000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Cash Equivalents: 160000000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Cash Financial: 337800000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Cash Financial: 337800000.00
DPM.AX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -291284000.00
DPM.AX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -11533000.00
DPM.AX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -497846000.00
DPM.AX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -49428000.00
DPM.AX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 652097000.00
DPM.AX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 145147000.00
DPM.AX cash_flow (annual, 2025-12-31) — Change In Inventory: 2268000.00
DPM.AX cash_flow (quarterly, 2025-12-31) — Change In Inventory: -2158000.00
DPM.AX cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: 71789000.00
DPM.AX cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: 42174000.00
DPM.AX cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -25269000.00
DPM.AX cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -46118000.00
DPM.AX cash_flow (annual, 2025-12-31) — Change In Receivables: 84947000.00
DPM.AX cash_flow (quarterly, 2025-12-31) — Change In Receivables: -46064000.00
DPM.AX cash_flow (annual, 2025-12-31) — Change In Working Capital: 133735000.00
DPM.AX cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -52166000.00
DPM.AX cash_flow (annual, 2025-12-31) — Changes In Account Receivables: 84947000.00
DPM.AX cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -46064000.00
DPM.AX cash_flow (annual, 2025-12-31) — Changes In Cash: -137033000.00
DPM.AX cash_flow (quarterly, 2025-12-31) — Changes In Cash: 84186000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Common Stock: 1581126000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Common Stock: 1581126000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Common Stock Equity: 2572114000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 2572114000.00
DPM.AX cash_flow (annual, 2025-12-31) — Common Stock Payments: -116135000.00
DPM.AX cash_flow (quarterly, 2025-12-31) — Common Stock Payments: 0.00
DPM.AX balance_sheet (annual, 2025-12-31) — Construction In Progress: 19761000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 19761000.00
DPM.AX income_statement (annual, 2025-12-31) — Cost Of Revenue: 344559000.00
DPM.AX income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 101002000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 84074000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 84074000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Current Assets: 809470000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Current Assets: 809470000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 5782000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 5782000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 5782000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 5782000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Current Liabilities: 225886000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 225886000.00
DPM.AX cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 107404000.00
DPM.AX cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 35360000.00
DPM.AX cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 107404000.00
DPM.AX cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 35360000.00
DPM.AX income_statement (annual, 2025-12-31) — Diluted Average Shares: 185707109.00
DPM.AX income_statement (annual, 2025-12-31) — Diluted EPS: 1.99
DPM.AX income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 369226000.00
DPM.AX income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 157338000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Dividends Payable: 8879000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Dividends Payable: 8879000.00
DPM.AX income_statement (annual, 2025-12-31) — EBIT: 424913000.00
DPM.AX income_statement (quarterly, 2025-12-31) — EBIT: 182349000.00
DPM.AX income_statement (annual, 2025-12-31) — EBITDA: 532317000.00
DPM.AX income_statement (quarterly, 2025-12-31) — EBITDA: 217709000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Employee Benefits: 40214000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Employee Benefits: 40214000.00
DPM.AX cash_flow (annual, 2025-12-31) — End Cash Position: 497797000.00
DPM.AX cash_flow (quarterly, 2025-12-31) — End Cash Position: 497797000.00
DPM.AX cash_flow (annual, 2025-12-31) — Financing Cash Flow: -291284000.00
DPM.AX cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -11533000.00
DPM.AX cash_flow (annual, 2025-12-31) — Free Cash Flow: 632015000.00
DPM.AX cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 139222000.00
DPM.AX cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: 27673000.00
DPM.AX cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: 9246000.00
DPM.AX cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of Business: 0.00
DPM.AX cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of Business: 0.00
DPM.AX income_statement (annual, 2025-12-31) — Gain On Sale Of Security: -7253000.00
DPM.AX income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: -2282000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -893000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -893000.00
DPM.AX income_statement (annual, 2025-12-31) — General And Administrative Expense: 86259000.00
DPM.AX income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 36969000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 12616000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 12616000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Gross PPE: 3060350000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Gross PPE: 3060350000.00
DPM.AX income_statement (annual, 2025-12-31) — Gross Profit: 605922000.00
DPM.AX income_statement (quarterly, 2025-12-31) — Gross Profit: 251432000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Income Tax Payable: 4862000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 4862000.00
DPM.AX income_statement (annual, 2025-12-31) — Interest Expense: 2934000.00
DPM.AX income_statement (quarterly, 2025-12-31) — Interest Expense: -683000.00
DPM.AX income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 2934000.00
DPM.AX income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: -683000.00
DPM.AX income_statement (annual, 2025-12-31) — Interest Income: 27933000.00
DPM.AX income_statement (quarterly, 2025-12-31) — Interest Income: 3023000.00
DPM.AX income_statement (annual, 2025-12-31) — Interest Income Non Operating: 27933000.00
DPM.AX income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 3023000.00
DPM.AX cash_flow (annual, 2025-12-31) — Interest Paid Cff: -2688000.00
DPM.AX cash_flow (quarterly, 2025-12-31) — Interest Paid Cff: -512000.00
DPM.AX cash_flow (annual, 2025-12-31) — Interest Received Cfo: 28447000.00
DPM.AX cash_flow (quarterly, 2025-12-31) — Interest Received Cfo: 3108000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Inventory: 55214000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Inventory: 55214000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Invested Capital: 2572114000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Invested Capital: 2572114000.00
DPM.AX cash_flow (annual, 2025-12-31) — Investing Cash Flow: -497846000.00
DPM.AX cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -49428000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 3323000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 3323000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Investments And Advances: 3323000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 3323000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 6640000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 6640000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 6640000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 6640000.00
DPM.AX cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -143685000.00
DPM.AX cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -2803000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Long Term Provisions: 37076000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Long Term Provisions: 37076000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 622175000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 622175000.00
DPM.AX cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: -399152000.00
DPM.AX cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: 0.00
DPM.AX cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -116135000.00
DPM.AX cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
DPM.AX income_statement (annual, 2025-12-31) — Net Income: 369226000.00
DPM.AX income_statement (quarterly, 2025-12-31) — Net Income: 157338000.00
DPM.AX income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 369226000.00
DPM.AX income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 157338000.00
DPM.AX income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 369226000.00
DPM.AX income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 157338000.00
DPM.AX income_statement (annual, 2025-12-31) — Net Income Discontinuous Operations: 0.00
DPM.AX income_statement (quarterly, 2025-12-31) — Net Income Discontinuous Operations: 0.00
DPM.AX income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 369226000.00
DPM.AX income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 157338000.00
DPM.AX income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 369226000.00
DPM.AX income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 157338000.00
DPM.AX cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 421979000.00
DPM.AX cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 183032000.00
DPM.AX income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 369226000.00
DPM.AX income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 157338000.00
DPM.AX income_statement (annual, 2025-12-31) — Net Interest Income: 23247000.00
DPM.AX income_statement (quarterly, 2025-12-31) — Net Interest Income: 1954000.00
DPM.AX cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 670000.00
DPM.AX cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 0.00
DPM.AX cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -143685000.00
DPM.AX cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -2803000.00
DPM.AX cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -143685000.00
DPM.AX cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -2803000.00
DPM.AX income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 23247000.00
DPM.AX income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 1954000.00
DPM.AX cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -984000.00
DPM.AX cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 0.00
DPM.AX cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -79282000.00
DPM.AX cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: -43503000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Net PPE: 2241440000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Net PPE: 2241440000.00
DPM.AX cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: 0.00
DPM.AX cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: 0.00
DPM.AX balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 2559498000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 2559498000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 6941000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 6941000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 154338000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 154338000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 6941000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 6941000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 154338000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 154338000.00
DPM.AX income_statement (annual, 2025-12-31) — Normalized EBITDA: 554976000.00
DPM.AX income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 219991000.00
DPM.AX income_statement (annual, 2025-12-31) — Normalized Income: 389052322.95
DPM.AX income_statement (quarterly, 2025-12-31) — Normalized Income: 159299653.24
DPM.AX cash_flow (annual, 2025-12-31) — Operating Cash Flow: 652097000.00
DPM.AX cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 145147000.00
DPM.AX cash_flow (annual, 2025-12-31) — Operating Gains Losses: 27673000.00
DPM.AX cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 9246000.00
DPM.AX income_statement (annual, 2025-12-31) — Operating Income: 430327000.00
DPM.AX income_statement (quarterly, 2025-12-31) — Operating Income: 192375000.00
DPM.AX income_statement (annual, 2025-12-31) — Operating Revenue: 950481000.00
DPM.AX income_statement (quarterly, 2025-12-31) — Operating Revenue: 352434000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 221981361.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 221981361.00
DPM.AX balance_sheet (annual, 2025-12-31) — Other Current Assets: 2663000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 2663000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 13379000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 13379000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -893000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -893000.00
DPM.AX income_statement (annual, 2025-12-31) — Other Gand A: 86259000.00
DPM.AX income_statement (quarterly, 2025-12-31) — Other Gand A: 36969000.00
DPM.AX income_statement (annual, 2025-12-31) — Other Income Expense: -31595000.00
DPM.AX income_statement (quarterly, 2025-12-31) — Other Income Expense: -11297000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 12616000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 12616000.00
DPM.AX cash_flow (annual, 2025-12-31) — Other Non Cash Items: -17413000.00
DPM.AX cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 17365000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 7590000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 7590000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 45112000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 45112000.00
DPM.AX income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -8936000.00
DPM.AX income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: -9015000.00
DPM.AX income_statement (annual, 2025-12-31) — Other Operating Expenses: 64960000.00
DPM.AX income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 22088000.00
DPM.AX income_statement (annual, 2025-12-31) — Other Taxes: 24376000.00
DPM.AX income_statement (quarterly, 2025-12-31) — Other Taxes: 0.00
DPM.AX balance_sheet (annual, 2025-12-31) — Payables: 77696000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Payables: 77696000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 161770000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 161770000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 44955000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 44955000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Prepaid Assets: 10759000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 10759000.00
DPM.AX income_statement (annual, 2025-12-31) — Pretax Income: 421979000.00
DPM.AX income_statement (quarterly, 2025-12-31) — Pretax Income: 183032000.00
DPM.AX cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 1624000.00
DPM.AX cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 677000.00
DPM.AX cash_flow (annual, 2025-12-31) — Purchase Of Business: -399152000.00
DPM.AX cash_flow (quarterly, 2025-12-31) — Purchase Of Business: 0.00
DPM.AX balance_sheet (annual, 2025-12-31) — Raw Materials: 55214000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Raw Materials: 55214000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Receivables: 243037000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Receivables: 243037000.00
DPM.AX income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 344559000.00
DPM.AX income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 101002000.00
DPM.AX income_statement (annual, 2025-12-31) — Reconciled Depreciation: 107404000.00
DPM.AX income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 35360000.00
DPM.AX cash_flow (annual, 2025-12-31) — Repayment Of Debt: -143685000.00
DPM.AX cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -2803000.00
DPM.AX cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -116135000.00
DPM.AX cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: 0.00
DPM.AX income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: 15406000.00
DPM.AX income_statement (quarterly, 2025-12-31) — Restructuring And Mergern Acquisition: 0.00
DPM.AX balance_sheet (annual, 2025-12-31) — Retained Earnings: 985712000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 985712000.00
DPM.AX cash_flow (annual, 2025-12-31) — Sale Of Business: 0.00
DPM.AX cash_flow (quarterly, 2025-12-31) — Sale Of Business: 0.00
DPM.AX cash_flow (annual, 2025-12-31) — Sale Of PPE: 0.00
DPM.AX cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 0.00
DPM.AX income_statement (annual, 2025-12-31) — Selling General And Administration: 86259000.00
DPM.AX income_statement (quarterly, 2025-12-31) — Selling General And Administration: 36969000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Share Issued: 221981361.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Share Issued: 221981361.00
DPM.AX income_statement (annual, 2025-12-31) — Special Income Charges: -15406000.00
DPM.AX income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
DPM.AX cash_flow (annual, 2025-12-31) — Stock Based Compensation: 906000.00
DPM.AX cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 231000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Stockholders Equity: 2572114000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 2572114000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Tangible Book Value: 2559498000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 2559498000.00
DPM.AX income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -2832677.05
DPM.AX income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -320346.76
DPM.AX income_statement (annual, 2025-12-31) — Tax Provision: 52753000.00
DPM.AX income_statement (quarterly, 2025-12-31) — Tax Provision: 25694000.00
DPM.AX income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.13
DPM.AX income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.14
DPM.AX balance_sheet (annual, 2025-12-31) — Taxes Receivable: 17779000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 17779000.00
DPM.AX cash_flow (annual, 2025-12-31) — Taxes Refund Paid: -50634000.00
DPM.AX cash_flow (quarterly, 2025-12-31) — Taxes Refund Paid: -25559000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Total Assets: 3081380000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Total Assets: 3081380000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Total Capitalization: 2572114000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 2572114000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Total Debt: 12422000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Total Debt: 12422000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 2572114000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 2572114000.00
DPM.AX income_statement (annual, 2025-12-31) — Total Expenses: 520154000.00
DPM.AX income_statement (quarterly, 2025-12-31) — Total Expenses: 160059000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 509266000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 509266000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 2271910000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 2271910000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 283380000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 283380000.00
DPM.AX income_statement (annual, 2025-12-31) — Total Other Finance Cost: 1752000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Total Tax Payable: 11936000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 11936000.00
DPM.AX income_statement (annual, 2025-12-31) — Total Unusual Items: -22659000.00
DPM.AX income_statement (quarterly, 2025-12-31) — Total Unusual Items: -2282000.00
DPM.AX income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -22659000.00
DPM.AX income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -2282000.00
DPM.AX balance_sheet (annual, 2025-12-31) — Working Capital: 583584000.00
DPM.AX balance_sheet (quarterly, 2025-12-31) — Working Capital: 583584000.00
DPM.AX income_statement (quarterly, 2026-03-31) — +Operating Expense: 39111000.00
DPM.AX income_statement (quarterly, 2026-03-31) — +Total Revenue: 310364000.00
DPM.AX balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 171547000.00
DPM.AX balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 273838000.00
DPM.AX balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 6100000.00
DPM.AX balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 4361000.00
DPM.AX income_statement (quarterly, 2026-03-31) — Basic Average Shares: 221216000.00
DPM.AX income_statement (quarterly, 2026-03-31) — Basic EPS: 0.75
DPM.AX cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 497797000.00
DPM.AX cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -3788000.00
DPM.AX cash_flow (quarterly, 2026-03-31) — Capital Expenditure Reported: -3788000.00
DPM.AX balance_sheet (quarterly, 2026-03-31) — Capital Stock: 1577277000.00
DPM.AX balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 575487000.00
DPM.AX balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 575487000.00
DPM.AX cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -8879000.00
DPM.AX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -38342000.00
DPM.AX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -38477000.00
DPM.AX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 154509000.00
DPM.AX cash_flow (quarterly, 2026-03-31) — Change In Inventory: -2633000.00
DPM.AX cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -1576000.00
DPM.AX cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -19317000.00
DPM.AX cash_flow (quarterly, 2026-03-31) — Change In Receivables: -29857000.00
DPM.AX cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -53383000.00
DPM.AX cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -29857000.00
DPM.AX cash_flow (quarterly, 2026-03-31) — Changes In Cash: 77690000.00
DPM.AX balance_sheet (quarterly, 2026-03-31) — Common Stock: 1577277000.00
DPM.AX cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -8879000.00
DPM.AX balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 2705236000.00
DPM.AX cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -24733000.00
DPM.AX income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 87268000.00
DPM.AX balance_sheet (quarterly, 2026-03-31) — Current Assets: 913328000.00
DPM.AX balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 210326000.00
DPM.AX cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 24632000.00
DPM.AX cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 24632000.00
DPM.AX income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 221216000.00
DPM.AX income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.75
DPM.AX income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 165912000.00
DPM.AX income_statement (quarterly, 2026-03-31) — EBIT: 190203000.00
DPM.AX income_statement (quarterly, 2026-03-31) — EBITDA: 214835000.00
DPM.AX balance_sheet (quarterly, 2026-03-31) — Employee Benefits: 45260000.00
DPM.AX cash_flow (quarterly, 2026-03-31) — End Cash Position: 575487000.00
DPM.AX balance_sheet (quarterly, 2026-03-31) — Financial Assets: 429000.00
DPM.AX cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -38342000.00
DPM.AX cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 150721000.00
DPM.AX cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: 18210000.00
DPM.AX balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 8000.00
DPM.AX income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 21952000.00
DPM.AX balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 11702000.00
DPM.AX income_statement (quarterly, 2026-03-31) — Gross Profit: 223096000.00
DPM.AX balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 23647000.00
DPM.AX income_statement (quarterly, 2026-03-31) — Interest Expense: 1088000.00
DPM.AX income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 1088000.00
DPM.AX income_statement (quarterly, 2026-03-31) — Interest Income: 3688000.00
DPM.AX income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 3688000.00
DPM.AX cash_flow (quarterly, 2026-03-31) — Interest Paid Cff: -606000.00
DPM.AX cash_flow (quarterly, 2026-03-31) — Interest Received Cfo: 3867000.00
DPM.AX balance_sheet (quarterly, 2026-03-31) — Inventory: 54906000.00
DPM.AX balance_sheet (quarterly, 2026-03-31) — Invested Capital: 2705236000.00
DPM.AX cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -38477000.00
DPM.AX balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 4361000.00
DPM.AX balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 4361000.00
DPM.AX cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -1978000.00
DPM.AX balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 36036000.00
DPM.AX cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -24733000.00
DPM.AX income_statement (quarterly, 2026-03-31) — Net Income: 165912000.00
DPM.AX income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 165912000.00
DPM.AX income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 165912000.00
DPM.AX income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 165912000.00
DPM.AX income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 165912000.00
DPM.AX cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 189115000.00
DPM.AX income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 165912000.00
DPM.AX income_statement (quarterly, 2026-03-31) — Net Interest Income: 2600000.00
DPM.AX cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -185000.00
DPM.AX cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -1978000.00
DPM.AX cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -1978000.00
DPM.AX income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 2600000.00
DPM.AX cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -2976000.00
DPM.AX cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: -34504000.00
DPM.AX balance_sheet (quarterly, 2026-03-31) — Net PPE: 2256382000.00
DPM.AX balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 2693534000.00
DPM.AX balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 6429000.00
DPM.AX balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 154338000.00
DPM.AX balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 6429000.00
DPM.AX balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 154338000.00
DPM.AX income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 214835000.00
DPM.AX income_statement (quarterly, 2026-03-31) — Normalized Income: 165912000.00
DPM.AX cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 154509000.00
DPM.AX cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 18210000.00
DPM.AX income_statement (quarterly, 2026-03-31) — Operating Income: 183985000.00
DPM.AX income_statement (quarterly, 2026-03-31) — Operating Revenue: 310364000.00
DPM.AX balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 221434508.00
DPM.AX balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 9097000.00
DPM.AX balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 15132000.00
DPM.AX balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 8000.00
DPM.AX income_statement (quarterly, 2026-03-31) — Other Gand A: 21952000.00
DPM.AX income_statement (quarterly, 2026-03-31) — Other Income Expense: 2530000.00
DPM.AX cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -28172000.00
DPM.AX balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 9642000.00
DPM.AX balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 51077000.00
DPM.AX income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 2530000.00
DPM.AX income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 17159000.00
DPM.AX balance_sheet (quarterly, 2026-03-31) — Payables: 195194000.00
DPM.AX balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 195194000.00
DPM.AX income_statement (quarterly, 2026-03-31) — Pretax Income: 189115000.00
DPM.AX cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 830000.00
DPM.AX cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -185000.00
DPM.AX balance_sheet (quarterly, 2026-03-31) — Receivables: 273838000.00
DPM.AX income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 87268000.00
DPM.AX income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 24632000.00
DPM.AX cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -1978000.00
DPM.AX cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -24733000.00
DPM.AX balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 1121851000.00
DPM.AX income_statement (quarterly, 2026-03-31) — Selling General And Administration: 21952000.00
DPM.AX balance_sheet (quarterly, 2026-03-31) — Share Issued: 221434508.00
DPM.AX cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 240000.00
DPM.AX balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 2705236000.00
DPM.AX balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 2693534000.00
DPM.AX income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
DPM.AX income_statement (quarterly, 2026-03-31) — Tax Provision: 23203000.00
DPM.AX income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.12
DPM.AX cash_flow (quarterly, 2026-03-31) — Taxes Refund Paid: 0.00
DPM.AX balance_sheet (quarterly, 2026-03-31) — Total Assets: 3202273000.00
DPM.AX balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 2705236000.00
DPM.AX balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 2705236000.00
DPM.AX income_statement (quarterly, 2026-03-31) — Total Expenses: 126379000.00
DPM.AX balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 497037000.00
DPM.AX balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 2288945000.00
DPM.AX balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 286711000.00
DPM.AX balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 23647000.00
DPM.AX balance_sheet (quarterly, 2026-03-31) — Working Capital: 703002000.00
DPM.TO cash_flow (annual, 2021-12-31) — Asset Impairment Charge: 0.00
DPM.TO balance_sheet (annual, 2021-12-31) — Cash Financial: 334377000.00
DPM.TO cash_flow (annual, 2021-12-31) — Cash Flow From Continuing Operating Activities: 253580000.00
DPM.TO cash_flow (annual, 2021-12-31) — Cash From Discontinued Financing Activities: -140000.00
DPM.TO cash_flow (annual, 2021-12-31) — Cash From Discontinued Operating Activities: -442000.00
DPM.TO cash_flow (annual, 2021-12-31) — Common Stock Issuance: 2810000.00
DPM.TO income_statement (annual, 2021-12-31) — Impairment Of Capital Assets: 0.00
DPM.TO cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 2810000.00
DPM.TO income_statement (annual, 2021-12-31) — Minority Interests: 277000.00
DPM.TO balance_sheet (annual, 2021-12-31) — Other Non Current Liabilities: 3081000.00
DPM.TO balance_sheet (annual, 2021-12-31) — Other Payable: 6518000.00
DPM.TO cash_flow (annual, 2021-12-31) — Purchase Of Business: -1569000.00
DPM.TO cash_flow (annual, 2021-12-31) — Purchase Of Investment: -8307000.00
DPM.TO cash_flow (annual, 2021-12-31) — Purchase Of PPE: -10100000.00
DPM.TO income_statement (annual, 2022-12-31) — +Operating Expense: 59013000.00
DPM.TO income_statement (annual, 2022-12-31) — +Total Revenue: 433490000.00
DPM.TO balance_sheet (annual, 2022-12-31) — Accounts Payable: 22025000.00
DPM.TO balance_sheet (annual, 2022-12-31) — Accounts Receivable: 113951000.00
DPM.TO balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -585023000.00
DPM.TO balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 6436000.00
DPM.TO cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 85000000.00
DPM.TO balance_sheet (annual, 2022-12-31) — Assets Held For Sale Current: 0.00
DPM.TO income_statement (annual, 2022-12-31) — Basic Average Shares: 190518584.00
DPM.TO income_statement (annual, 2022-12-31) — Basic EPS: 0.19
DPM.TO cash_flow (annual, 2022-12-31) — Beginning Cash Position: 334377000.00
DPM.TO balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 72304000.00
DPM.TO cash_flow (annual, 2022-12-31) — Capital Expenditure: -30219000.00
DPM.TO cash_flow (annual, 2022-12-31) — Capital Expenditure Reported: -30219000.00
DPM.TO balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 14584000.00
DPM.TO balance_sheet (annual, 2022-12-31) — Capital Stock: 583027000.00
DPM.TO balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 433176000.00
DPM.TO balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 433176000.00
DPM.TO cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -28606000.00
DPM.TO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -44655000.00
DPM.TO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -66957000.00
DPM.TO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 209589000.00
DPM.TO cash_flow (annual, 2022-12-31) — Cash From Discontinued Financing Activities: -2789000.00
DPM.TO cash_flow (annual, 2022-12-31) — Cash From Discontinued Investing Activities: -18852000.00
DPM.TO cash_flow (annual, 2022-12-31) — Cash From Discontinued Operating Activities: 22463000.00
DPM.TO cash_flow (annual, 2022-12-31) — Change In Inventory: 642000.00
DPM.TO cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -1367000.00
DPM.TO cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 5104000.00
DPM.TO cash_flow (annual, 2022-12-31) — Change In Receivables: 14339000.00
DPM.TO cash_flow (annual, 2022-12-31) — Change In Working Capital: 18718000.00
DPM.TO cash_flow (annual, 2022-12-31) — Changes In Account Receivables: 14339000.00
DPM.TO cash_flow (annual, 2022-12-31) — Changes In Cash: 98799000.00
DPM.TO balance_sheet (annual, 2022-12-31) — Common Stock: 583027000.00
DPM.TO balance_sheet (annual, 2022-12-31) — Common Stock Equity: 993094000.00
DPM.TO cash_flow (annual, 2022-12-31) — Common Stock Issuance: 3377000.00
DPM.TO cash_flow (annual, 2022-12-31) — Common Stock Payments: -13619000.00
DPM.TO balance_sheet (annual, 2022-12-31) — Construction In Progress: 21443000.00
DPM.TO income_statement (annual, 2022-12-31) — Cost Of Revenue: 236668000.00
DPM.TO balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 40824000.00
DPM.TO balance_sheet (annual, 2022-12-31) — Current Assets: 610921000.00
DPM.TO balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 4543000.00
DPM.TO balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 4543000.00
DPM.TO balance_sheet (annual, 2022-12-31) — Current Liabilities: 96885000.00
DPM.TO cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 84229000.00
DPM.TO cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 84229000.00
DPM.TO income_statement (annual, 2022-12-31) — Diluted Average Shares: 191157592.00
DPM.TO income_statement (annual, 2022-12-31) — Diluted EPS: 0.19
DPM.TO income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 35923000.00
DPM.TO balance_sheet (annual, 2022-12-31) — Dividends Payable: 7600000.00
DPM.TO income_statement (annual, 2022-12-31) — EBIT: 141844000.00
DPM.TO income_statement (annual, 2022-12-31) — EBITDA: 226073000.00
DPM.TO balance_sheet (annual, 2022-12-31) — Employee Benefits: 8122000.00
DPM.TO cash_flow (annual, 2022-12-31) — End Cash Position: 433176000.00
DPM.TO cash_flow (annual, 2022-12-31) — Financing Cash Flow: -47444000.00
DPM.TO cash_flow (annual, 2022-12-31) — Free Cash Flow: 201833000.00
DPM.TO cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: -5548000.00
DPM.TO income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -1017000.00
DPM.TO balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -8155000.00
DPM.TO income_statement (annual, 2022-12-31) — General And Administrative Expense: 28543000.00
DPM.TO balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 15501000.00
DPM.TO balance_sheet (annual, 2022-12-31) — Gross PPE: 1061877000.00
DPM.TO income_statement (annual, 2022-12-31) — Gross Profit: 196822000.00
DPM.TO income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 85000000.00
DPM.TO balance_sheet (annual, 2022-12-31) — Income Tax Payable: 83000.00
DPM.TO income_statement (annual, 2022-12-31) — Interest Expense: 2441000.00
DPM.TO income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 2441000.00
DPM.TO income_statement (annual, 2022-12-31) — Interest Income: 6494000.00
DPM.TO income_statement (annual, 2022-12-31) — Interest Income Non Operating: 6494000.00
DPM.TO cash_flow (annual, 2022-12-31) — Interest Paid Cff: -3223000.00
DPM.TO cash_flow (annual, 2022-12-31) — Interest Received Cfo: 6565000.00
DPM.TO balance_sheet (annual, 2022-12-31) — Inventory: 45813000.00
DPM.TO balance_sheet (annual, 2022-12-31) — Invested Capital: 993094000.00
DPM.TO cash_flow (annual, 2022-12-31) — Investing Cash Flow: -85809000.00
DPM.TO balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 40773000.00
DPM.TO balance_sheet (annual, 2022-12-31) — Investments And Advances: 40773000.00
DPM.TO cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 3377000.00
DPM.TO balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 10041000.00
DPM.TO balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 10041000.00
DPM.TO balance_sheet (annual, 2022-12-31) — Long Term Provisions: 45823000.00
DPM.TO balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 504940000.00
DPM.TO income_statement (annual, 2022-12-31) — Minority Interests: 0.00
DPM.TO cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 0.00
DPM.TO cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -13619000.00
DPM.TO cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: -3029000.00
DPM.TO income_statement (annual, 2022-12-31) — Net Income: 35923000.00
DPM.TO income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 35923000.00
DPM.TO income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 116584000.00
DPM.TO income_statement (annual, 2022-12-31) — Net Income Discontinuous Operations: -80661000.00
DPM.TO income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 35923000.00
DPM.TO income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 116584000.00
DPM.TO cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 139402000.00
DPM.TO income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 35923000.00
DPM.TO income_statement (annual, 2022-12-31) — Net Interest Income: 3154000.00
DPM.TO cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -500000.00
DPM.TO cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -2584000.00
DPM.TO cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -2584000.00
DPM.TO income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 3154000.00
DPM.TO cash_flow (annual, 2022-12-31) — Net Other Investing Changes: -36243000.00
DPM.TO balance_sheet (annual, 2022-12-31) — Net PPE: 476854000.00
DPM.TO cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: 5000.00
DPM.TO balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 977593000.00
DPM.TO balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 6590000.00
DPM.TO balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 6590000.00
DPM.TO income_statement (annual, 2022-12-31) — Normalized EBITDA: 227090000.00
DPM.TO income_statement (annual, 2022-12-31) — Normalized Income: 117434526.37
DPM.TO cash_flow (annual, 2022-12-31) — Operating Cash Flow: 232052000.00
DPM.TO cash_flow (annual, 2022-12-31) — Operating Gains Losses: -8577000.00
DPM.TO income_statement (annual, 2022-12-31) — Operating Income: 137809000.00
DPM.TO income_statement (annual, 2022-12-31) — Operating Revenue: 433490000.00
DPM.TO balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 190000202.00
DPM.TO balance_sheet (annual, 2022-12-31) — Other Current Assets: 5495000.00
DPM.TO balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 11094000.00
DPM.TO balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -8155000.00